Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Consolidated Balance Sheets (Unaudited) (Parentheticals)

v3.22.1
Consolidated Balance Sheets (Unaudited) (Parentheticals)
Mar. 31, 2022
USD ($)
shares
Mar. 31, 2022
₪ / shares
Dec. 31, 2021
USD ($)
shares
Dec. 31, 2021
₪ / shares
Statement of Financial Position [Abstract]        
Accounts receivable, net of allowance for credit losses (in Dollars) | $ $ 700   $ 500  
Ordinary shares, par value (in New Shekels per share) | ₪ / shares   ₪ 10.00   ₪ 10.00
Ordinary shares, authorized 180,000   180,000  
Ordinary shares, issued 66,408   65,677  
Ordinary shares, outstanding 66,408   65,677